ESC 365 - STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial

Back

Open Access

STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial

Session: HOT LINE 1

Topic: Angiotensin-Renin-Bradykinin System

Speaker: Professor M. Legrand (San Francisco, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Matthieu Legrand

University of California at San Francisco, San Francisco (United States of America)

2 presentations

0 follower

8 more presentations in this session

HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy

Speaker: Professor M. Fontana (London, GB)

Discussant review - HELIOS-B

Speaker: Doctor S. Cuddy (Boston, US)

Access

Slides

Video

Panel discussion - HELIOS-B

Access

Video

Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control

Speaker: Professor J. Silvain (Paris, FR)

Discussant review - ABYSS

Speaker: Professor J. Armitage (Oxford, GB)

Access

Slides

Video

Access the full session

HOT LINE 1

Speakers: Professor M. Legrand, Professor M. Fontana, Doctor S. Cuddy, Professor J. Silvain, Professor J. Armitage

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources